Kretto Syscon Ltd.
Fundamentals
- Market cap
- ₹38.61 cr
- P/E
- 19.13×
- ROE
- 6.09%
- Debt / equity
- 0.01
- 52-week range
- 0.45 — 2.06
Company snapshot
Kretto Syscon Ltd.
Pharmaceuticals
₹40 cr
P/E 19.80×
Latest quarter · Mar 2026
Sales₹1 cr
Net profit−₹0 cr
Op. margin−35.8%
EPS−₹0.01
Strength & growth
Debt / equity0.01×
Current ratio7.22×
Sales CAGR−4.5%
EPS CAGR+16.9%
The timeline — 2 notes on Kretto Syscon Ltd.
May 2026
- 26 May 26 · 7:28 PM IST Brief Brief · Earnings · Micro cap
Kretto Syscon revenue halves as FY26 profit drops to ₹201.77 lakhs
The nano-cap firm confirmed audited results showing a sharp decline in annual performance, with Q4 slipping into a loss.
- 26 May 26 · 7:25 PM IST Brief Brief · Earnings · Micro cap
Kretto Syscon revenue halves as annual profit drops to ₹201.77 lakhs
The company reported FY26 revenue of ₹589.89 lakhs, down from ₹1,169.40 lakhs in the prior year, while reserves fell to ₹186.59 lakhs.